On Wednesday 24th November, a Stroke Awareness Event was held at the University of Oxford, with the aim of raising awareness about stroke, stroke services and stroke research.
Up to 70% of stroke survivors complain of tiredness or fatigue, sometimes years after stroke. Unlike normal tiredness, post stroke fatigue does not always respond to rest. The cause of extreme tiredness is not known and there are no definitive treatments available.
We want to ensure that you have everything you need to make your event fun, but also to keep it safe and legal. Here's all the information we think you’ll need, but we are always here to help if you want further information or advice.
This Lectureship will explore the link between tests that are used to assess cognition (memory and thinking) after a stroke and measurements of stroke survivor's functional abilities. It will also investigate how cognition and functional ability change over time.
In a new guest blog, published on the Evidently Cochrane website, Annette shares her story of living with dysarthria after stroke. Claire Mitchell, Speech and Language Therapist and author of a newly updated Cochrane Review on dysarthria, explains the findings.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
As part of our research programme, we fund exceptional candidates from stroke professional backgrounds to our prestigious Postgraduate and Postdoctoral Fellowship positions. Meet our new fellows for 2017.
Stroke survivors can be referred to Moving Forward After Stroke for a 12-week exercise programme. Exercise can help reduce the risk of an individual suffering a second stroke, and helps survivors to overcome challenges they face following the physical impact of their stroke.
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.